Literature DB >> 6091900

Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

J B Bolen, C J Thiele, M A Israel, W Yonemoto, L A Lipsich, J S Brugge.   

Abstract

We examine the interaction between polyoma-virus-encoded middle tumor antigen and the cellular src gene product, pp60c-src, using a series of monoclonal antibodies that recognize mammalian pp60c-src. Our results show that infection of mouse cells with transformation-competent strains of polyoma virus results in the stimulation of pp60c-src kinase activity severalfold over that observed in uninfected mouse cells and mouse cells infected with transformation-deficient polyoma virus. A similar degree of enhancement of pp60c-src kinase activity was found in polyoma-virus-transformed rodent cells. No differences were detected in the level of pp60c-src synthesis in polyoma-virus-infected and uninfected mouse cells or polyoma-virus-transformed and normal rodent cells. These studies demonstrate that polyoma-virus-encoded middle tumor antigen is associated with pp60c-src in lysates of polyoma-virus-infected and polyoma-virus-transformed cells and suggest a novel mechanism for the functional activation of a cellular proto-oncogene product, namely, that the interaction between middle tumor antigen and pp60c-src leads to a stimulation of pp60c-src tyrosyl kinase activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091900     DOI: 10.1016/0092-8674(84)90272-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  152 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase.

Authors:  E T Ulug; A J Cartwright; S A Courtneidge
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.

Authors:  L Petti; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Authors:  A L Burkhardt; J B Bolen; E Kieff; R Longnecker
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.

Authors:  M Yoakim; W Hou; Y Liu; C L Carpenter; R Kapeller; B S Schaffhausen
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

6.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses.

Authors:  J Forstová; N Krauzewicz; B E Griffin
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

8.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

9.  Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation.

Authors:  M Whitman; D Kaplan; T Roberts; L Cantley
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

10.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.